MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness
Dr Simon Hart S.Hart@hull.ac.uk
Reader in Respiratory Medicine
Dr Mark Pearson Mark.Pearson@hull.ac.uk
Reader in Implementation Science
Professor Miriam Johnson Miriam.Johnson@hull.ac.uk
A parallel group, double-blind, randomised placebo-controlled trial comparing the efficacy and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of breathlessness and daily activity in people with chronic breathlessness.
|Funder(s)||National Institute for Health Research|
|Project Dates||Mar 1, 2019 - Feb 29, 2024|
You might also like
Liverpool-Humber Optimisation of Freight Transport May 1, 2017 - Jan 31, 2021
The LHOFT Project - Liverpool - Humber Optimisation of Freight Transport uniquely brings together the combined strength of a major cargo owner (Unilever) the two key port operators at each end of the M62 corridor (ABP on the Humber and Peel Ports on... Read More about Liverpool-Humber Optimisation of Freight Transport.
TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research Sep 1, 2017 - Dec 31, 2026
The death rate is higher in Yorkshire than the rest of England resulting in about 200 extra deaths each year of which more than half are in Hull. There are other significant cancer outcome inequalities between different groups; for example poorer pe... Read More about TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research.
Development and application of a multi-scale computational model of sarcoidosis to predict therapeutic approaches for non-self-resolving disease Jun 30, 2017 - Aug 31, 2020
An in silico computational model of sarcoidosis